Pfizer (PFE)

Pfizer Inc. (NYSE:PFE) y Alliance Foundation Trials, LLC (AFT) anunciaron hoy los resultados del ensayo de fase 3 PATINA

https://investors.pfizer.com/Investors/News/news-details/2024/Pfizers-IBRANCE-in-Combination-with-Standard-of-Care-Therapies-Extends-Median-Progression-Free-Survival-by-Over-15-Months-in-Phase-3-PATINA-Study-in-Patients-with-HR-HER2-Metastatic-Breast-Cancer/default.aspx

6 Me gusta

GUIDANCE actualizado:

https://investors.pfizer.com/Investors/News/news-details/2024/Pfizer-Provides-Full-Year-2025-Guidance-and-Reaffirms-Full-Year-2024-Guidance/default.aspx

12 Me gusta

Aprobación FDA

https://investors.pfizer.com/Investors/News/news-details/2024/U.S.-FDA-Approves-Pfizers-BRAFTOVI-Combination-Regimen-as-First-Line-Treatment-of-BRAF-V600E-Mutant-Metastatic-Colorectal-Cancer/default.aspx

5 Me gusta